OrPro Therapeutics
Blood & Organ Banks · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3210 Merryfield Row, San Diego, Californ...Phone Number
(858) 242-1557Website
www.orprotherapeutics.comRevenue
<$5 MillionIndustry
About OrPro Therapeutics
OrPro Therapeutics, Inc. is focused on developing the Theradux non-systemic biologic drug platform aimed at treating lung diseases and other epithelial surface conditions characterized by chronic infection, inflammation, and obstructive mucus. The company is particularly addressing cystic fibrosis, where thick mucus severely impacts lung function. Additionally, OrPro is working on ORP100S, a novel biologic therapy designed to alleviate inflammation and obstruction in the lungs related to chronic airway disorders and severe COVID-19. Their intended clients include patients suffering from these respiratory conditions.Explore more
OrPro Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to OrPro Therapeutics
Compare insights from companies similar to OrPro Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
OrPro Therapeutics Tech Stack
A closer look at the technologies used by OrPro Therapeutics
See more technologies
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OrPro Therapeutics
Sign Up For FreeTo access detailed company insights
OrPro Therapeutics, Inc. is focused on developing the Theradux non-systemic biologic drug platform aimed at treating lung diseases and other epithelial surface conditions characterized by chronic infection, inflammation, and obstructive mucus. The company is particularly addressing cystic fibrosis, where thick mucus severely impacts lung function.... Read More
